Purmorphamine as a Novel Osteoinductive Molecule: A Systematic Review
Introduction: Small molecules are active substances which are used in bone tissue engineering. They present great characteristics including induction of developmental genes, bioavailability and easy metabolism. Purmorphamine is a small molecule which has been demonstrated to exert osteogenic effects. In the present study we aimed to review present literature regarding the osteogenic effect of purmorphamine.
Materials and Methods: The MEDLINE (NCBI PubMed and PMC), Google Scholar and Scopus were searched by the following keywords “purmorphamine” AND “osteogenesis” OR “osteogenic differentiation” OR “bone formation”. According to PRISMA statement, all in vivo and in vitro studies conducted on osteogenic effect of purmorphamine were included. Search was limited to English-language studies up to February 2020.
Results: Finally, 16 studies were included and the data were extracted. Data were categorized by the studied cell type, purmorphamine dosage and treatment groups, scaffolds and results.
Conclusion: It is demonstrated that purmorphamine may be effective in osteogenic differentiation of various cells but this effect may vary by applied dosage and duration.
A signature of author below certifies compliance with the following statements:
Copyright transfer; in signing this Agreement:
1. I hereby warrant that this article is an original work, has not been published before and is not being considered for publication elsewhere in its final form either in printed or electronic form;
2. I hereby warrant that you have obtained permission from the copyright holder to reproduce in the Article (in all media including print and electronic form) material not owned by you, and that you have acknowledged the source;
3. I hereby warrant that this article contains no violation of any existing copyright, moral rights or other third party right or any material of an obscene, indecent, defamatory or otherwise unlawful nature and that to the best of your knowledge this Article does not infringe the rights of others;
4. I hereby warrant that in the case of a multi-authored Article you have obtained, in writing, authorization to enter into this Agreement on their behalf and that all co-authors have read and agreed the terms of this agreement;
5. I warrant that any formula or dosage given is accurate and will not if properly followed injure any person;
6. I have made a significant scientific contribution to the study and I have read the complete manuscript and take responsibility for the content and completeness of the final surmised manuscript;
7. I will indemnify and keep indemnified the Editors, the Regeneration, Reconstruction and Restoration journal's editor against all claims and expenses (including legal costs and expenses) arising from any breach of this warranty and the other warranties on your behalf in this Agreement.
Conflict of interest disclosure
All institutional or corporeal affixations of mine and all funding sources for the study are acknowledged. I certify that I have no commercial association that might represent a conflict of interest in connection with the submitted manuscript.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.